Industry Sponsored Symposia
Thursday 7 July 2016
| 11:00-12:00 | Didactic Session 1: Sulodexide (Supported by an educational grant from Alfa Wassermann)
Chairmen: Andrew Nicolaides (Cyprus), Guiseppe Maria Andreozzi (Italy) |
| 11:00 | Biomarkers in chronic venous disease and deep venous disease. Ferdinando Mannello (Italy) |
| 11:15 | Sulodexide in chronic venous disease and deep venous disease recurrence. Tomasz Urbanek (Poland) |
| 11:30 | Pharmacological rationale behind the clinical effects of Sulodexide. Jawed Fareed (USA) |
| 11:45 | Discussion. Moderator: Andrew Nicolaides (Cyprus) |
Thursday 7 July 2016
| 16:30-17:30 | Didactic Session 4: Lymphoedema (Supported by an educational grant from Sigvaris)
Chairmen: Christine Moffat (UK), Sophie Renton (UK) |
| 16:30-16:45 | The new classification of primary lymphatic dysplasias and prognosis. Sohar Mansour (UK) |
| 16:45-17:00 | The Management of lymphedema including the patient journey. Tracy Green (UK) |
| 17:00-17:15 | The use of compression therapy and IPC in the management of lymphedema. Christine Moffat (UK) |
| 17:15-17:30 | Discussion |
Friday 8 July 2016
| 11:00-12:00 | Didactic Session 5: The place of ruscus extract + HMC + VitC in the management of chronic venous disease (Supported by an educational grant from Pierre Fabre)
Chairmen: Andrew Nicolaides (Cyprus), Pavel Poredos (Slonenia) |
| 11:00-11:15 | Muscarinic receptors in chronic venous disease and the effect of Ruscus. Eliete Bouskela (Brazil) |
| 11:15-11:30 | Chronic venous disease pathophysiology update. Arkadiusz Jawien (Poland) |
| 11:30-11:45 | Update on Ruscus extract + HMC + VitC comprehensive mode of action and efficacy. Francois-André Allaert (France) |
| 11:45-12:00 | Panel Discussion and Conclusions. |